tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Posts Tagged 'Dr. Mark Rabe'

Nuvilex, Inc. Engaged in “Cutting Edge” Cannabis Preclinical Studies Using Model Compounds with Cell-in-a-Box

Written by Ι Stock Market Media Group Staff — October 29, 2014

New York, NY – Nuvilex, Inc. (OTCQB: NVLX) isn’t letting the upcoming mid-term elections or the views in Washington, D.C., on medical marijuana slow down its research.  The company is currently engaged in preclinical studies at the University of Northern Colorado (UNC) targeting Cannabis-based cancer treatments using Nuvilex’s Cell-in-a-Box® cellulose-based live cell encapsulation technology. 

While waiting for a Schedule 1 license from the DEA in order to conduct research using marijuana, Dr. ...

Read More →
0

Congressional Legislators Agree with Nuvilex’s Dr. Mark Rabe on Reclassifying Marijuana

Written by ι Stock Market Media Group — February 14, 2014

Nuvilex, Inc.’s (OTCQB: NVLX) Dr. Mark L. Rabe has something in common with 18 members of Congress.  All of them want marijuana reclassified from its current listing as a dangerous drug with no medical value, and they want President Obama to use his authority to make that change by removing marijuana from the Schedule I category.  Currently marijuana is viewed in the same category as drugs like heroin and LSD, and in ...

Read More →
0

Nuvilex’s Dr. Mark Rabe Talks Medical Marijuana, Legalization and Cell-in-a-Box

Nuvilex’s Dr. Mark Rabe Talks Medical Marijuana, Legalization and Cell-in-a-Box

Written by ι Stock Market Media Group — February 12, 2014

Nuvilex, Inc. (OTCQB: NVLX) is a biotechnology company that’s focused on getting into late phase clinical trials for the treatment of advanced, inoperable pancreatic cancer, but it also expects to be a major player in the medical marijuana arena.  And, to that end, last December, Nuvilex landed a leading figure in the medical marijuana field in Dr. Mark L. Rabe.  Dr. Rabe was appointed as the Chairman of the Scientific Advisory Board ...

Read More →
0
ContactUs.com